Cullinan Therapeutics reported cash from operations of -$38.22M and free cash flow of -$38.22M for the quarter ended Jun 2026, up 33.7% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||
| Net Income | -18.26M | -34.21M | -12.86M | 174.06M | -24.89M | -27.07M | -58.14M | -32.21M | -39.18M | -25.56M | -37.30M | -41.96M | -40.47M | -47.54M | -48.42M | -69.87M | -50.50M | -50.64M | -49.60M | -53.61M | ||||||
| Share-based Compensation | 4.62M | 12.14M | 6.57M | 8.61M | 5.27M | 7.51M | 7.26M | 7.92M | 7.74M | 7.52M | 8.23M | 10.53M | 9.43M | 9.63M | 9.37M | 9.89M | 9.47M | 7.31M | 7.62M | 8.45M | ||||||
| Deferred Taxes | -19.57M | |||||||||||||||||||||||||
| Asset Writedowns and Impairment | 0.40M | |||||||||||||||||||||||||
| Cash from Operations | -10.55M | -15.17M | -21.91M | -25.42M | -54.35M | -24.98M | -51.00M | -31.01M | -34.14M | -18.13M | -38.25M | -36.29M | -34.14M | -36.63M | -43.16M | -57.61M | -36.88M | -38.11M | -46.05M | -38.22M | ||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.06M | 0.07M | 0.08M | 0.08M | 0.08M | 0.08M | 0.08M | 0.08M | 0.08M | 0.08M | 0.08M | 0.08M | 0.08M | 0.08M | 0.08M | ||||||
| Change in Working Capital | ||||||||||||||||||||||||||
| Change in Account Payables | 0.52M | 1.15M | 3.14M | -3.21M | -1.58M | 1.15M | -0.63M | 0.46M | -1.54M | 1.54M | 1.21M | -2.15M | 0.56M | -0.43M | 1.72M | -0.94M | -0.74M | -0.88M | 1.67M | 1.22M | ||||||
| Change in Accured Expenses | 1.60M | 2.77M | 1.03M | 4.69M | 1.23M | 1.58M | 2.64M | -2.82M | 5.17M | 5.06M | -7.53M | 3.60M | -0.06M | 6.89M | -5.25M | 1.61M | 5.49M | 6.18M | -4.31M | 4.21M | ||||||
| Change in Taxes | 46.50M | -35.10M | -7.12M | -0.07M | -4.21M | |||||||||||||||||||||
| Other Working Capital Changes | -0.10M | -1.83M | 1.14M | -0.09M | -0.54M | 0.62M | 0.76M | -1.92M | 3.81M | 3.29M | -0.41M | 2.59M | -1.34M | 1.64M | -1.74M | -3.52M | -0.80M | -0.84M | 0.66M | -2.09M | ||||||
| Investing Activities | ||||||||||||||||||||||||||
| Capital Expenditures | 0.25M | 0.88M | 0.16M | 0.05M | 0.01M | |||||||||||||||||||||
| Change in Acquisitions & Divestments | 59.71M | 61.40M | 91.73M | 67.20M | 61.40M | 132.60M | 104.48M | 93.61M | 93.82M | 117.48M | 144.32M | 139.82M | 116.67M | 184.00M | 162.65M | 131.93M | 80.00M | 42.00M | 52.55M | 55.25M | ||||||
| Cash from Investing Activities | -25.59M | -15.86M | 34.71M | 300.85M | -57.98M | -28.61M | 15.18M | 12.11M | -42.96M | 51.47M | 12.96M | -185.11M | 19.88M | 15.96M | 36.80M | 53.40M | 67.39M | 22.39M | 32.41M | 40.68M | ||||||
| Financing Activities | ||||||||||||||||||||||||||
| Other financing activities | 1.15M | |||||||||||||||||||||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||||
| Long-Term Debt Issuances | 0.80M | 1.40M | ||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 5.48M | 2.89M | 2.09M | 3.00M | 2.73M | |||||||||||||||||||||
| Net Equity Issued and Repurchased | 0.58M | 2.70M | 1.59M | 0.61M | 0.17M | 1.82M | 36.56M | 262.65M | ||||||||||||||||||
| Dividend Payments | ||||||||||||||||||||||||||
| Dividends Paid - Common | 3.79M | 0.66M | ||||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||
| Cash from Financing Activities | 0.58M | 2.70M | 3.54M | 2.01M | 1.43M | -32.91M | 1.79M | 38.60M | 0.11M | 0.25M | 1.08M | 262.20M | 1.32M | 1.58M | 0.37M | 0.71M | 0.38M | 1.10M | ||||||||
| Change in Cash | -35.56M | -28.33M | 16.34M | 277.44M | -110.91M | -86.50M | -34.02M | 19.71M | -76.99M | 33.59M | -24.21M | 40.79M | -12.94M | -19.08M | -6.35M | -3.83M | 30.52M | -15.00M | -13.25M | 3.56M | ||||||
| Free Cash Flow | -10.55M | -15.17M | -21.91M | -25.42M | -54.60M | -25.86M | -51.16M | -31.05M | -34.14M | -18.13M | -38.25M | -36.29M | -34.14M | -36.63M | -43.16M | -57.61M | -36.88M | -38.12M | -46.05M | -38.22M | ||||||
| Net Cash Flow | -35.56M | -28.33M | 16.34M | 277.44M | -110.91M | -86.50M | -34.02M | 19.71M | -76.99M | 33.59M | -24.21M | 40.79M | -12.94M | -19.08M | -6.35M | -3.83M | 30.52M | -15.00M | -13.25M | 3.56M |